Recent findings indicate that the transfer of nicotinamide phosphoribosyltransferase (NAMPT) through microvesicles from radio-resistant glioma stem cells can enhance intracellular NAD+ levels in recipient cells, thereby promoting their resistance to radiation therapy [11]. This evidence concerns the gene NAMPT and glioma.